Tryptamine Therapeutics Limited
TYPTF
$0.01
$0.00-6.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.98M | 1.89M | 1.78M | 1.99M | 1.52M |
| Total Receivables | 1.81M | 1.72M | 871.80K | 976.70K | 35.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 368.80K | 350.90K | 334.00K | 374.20K | 26.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 23.70K |
| Total Current Assets | 4.16M | 3.96M | 2.98M | 3.34M | 1.61M |
|
|
|||||
| Total Current Assets | 4.16M | 3.96M | 2.98M | 3.34M | 1.61M |
| Net Property, Plant & Equipment | 75.20K | 71.50K | 73.40K | 82.30K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 128.20K | 121.90K | 220.10K | 246.60K | 126.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.40K | 1.40K | 1.40K | 1.50K | -- |
| Total Assets | 4.37M | 4.16M | 3.28M | 3.67M | 1.73M |
|
|
|||||
| Total Accounts Payable | 144.60K | 137.60K | 570.50K | 639.10K | 1.42M |
| Total Accrued Expenses | 307.50K | 292.50K | 54.30K | 60.90K | 22.70K |
| Short-term Debt | -- | -- | 30.80K | 34.50K | 3.69M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 6.20K | 5.90K | -- | -- | -- |
| Total Other Current Liabilities | 6.20K | 5.90K | -- | -- | -- |
| Total Current Liabilities | 458.40K | 436.10K | 655.60K | 734.50K | 5.13M |
|
|
|||||
| Total Current Liabilities | 458.40K | 436.10K | 655.60K | 734.50K | 5.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 30.80K | 34.50K | 3.69M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 203.60K |
| Total Liabilities | 458.40K | 436.10K | 655.60K | 734.50K | 5.34M |
|
|
|||||
| Common Stock & APIC | 23.15M | 22.02M | 20.09M | 22.51M | 12.56M |
| Retained Earnings | -23.21M | -22.08M | -21.10M | -23.64M | -16.65M |
| Treasury Stock & Other | 3.97M | 3.78M | 3.63M | 4.07M | 482.60K |
| Total Common Equity | 3.91M | 3.72M | 2.62M | 2.94M | -3.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.91M | 3.72M | 2.62M | 2.94M | -3.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.91M | 3.72M | 2.62M | 2.94M | -3.60M |
|
|
|||||